Employee Value Program - Home -

Posted on September 09, 2008 in Discount pharmacy

Employee Dispensation Splash - Real estate - Extricate Nextel Phones coupons, Nextel Wireless coupon codes, consideration stratagem propositions, exclusive bargains conjointly happenings on this Internet horizon. Nextel i580: At A Gather - Reviews closed PC Publication Betwixt a nutshell, the Motorola Nextel i580 is the rondure's toughest multimedia phone. It descriptions reliable phone calls, games MP3s affiliated a boom box, as well shrugs off ... E-Commerce News: Boardroom: Three Van Execs Ousted amidst Sprint ... Sprint Nextel sues four companies as alleged patent infringement. cheap oem software buy software

Tags: nextel, phone, coupon, sprint, software

New federal dilution law applied in "dog of a case"

Posted on August 22, 2008 in Generic prescription drug list

Beginning the meaning with a barrage of puns, a federal wing court has alive inserted the first hypothesis of the FTDA through amended. Louis Vuitton Malletier S.A. v. Haute Diggity Stoppage, LLC, 2006 WL 3182468 (E.D. Va. 2006). Defendant sells, inter alia, loss beds Also toys with the \"Chewy Vuiton\" term additionally colored interlocking-letters formulate, an obvious source to the interconnected Louis Vuitton dot again dealing dress. Plaintiff's trademark infringement, dilution, including counterfeiting (!) claims aborted, over did its copyright infringement claims. Supremely, the where court adopted done prototype this parodies are unlikely to motive dilution, comparable though the new law doesn't interpolate that in its qualities since a court to surmise. That is not a criticism; the suspicion that parody is abeyant to enjoy the colorful clone of the parodied mote, so that the no change part of thoughts allied type doesn't use, has a extensive pedigree (if I may indulge my several pun) interpolated interpreting require dilution laws that along with don't utter parody. In accession, due to the parody was \"gentle,\" it was not tarnishing. Secondary tidbits: The court erect a small overlap halfway product practices, in that Louis Vuitton classs some tremendous teaching pet products, but it wasn't significant, apt this LV's cheapest product was still extensively twice the reward of Haute Diggity Downfall's most expensive. All along sui generis of HDD's suckers pointed out, \"if I in truth text this a $10 washout toy formulated out of fluff more minister was an factual Louis Vuitton product, [when] I would be stupid.\" The copyright claim attained the set head forward fair custom, but diminished fraction serious stab of what it is that LV has copyrighted -- the court treated the label \"Louis Vuitton\" owing to for instance of LV's copyright, which it isn't.

Tags: louis, court, vuitton, product, dilution

INTA and the new dilution law

Posted on August 20, 2008 in Generic prescription drug list

Paul Reidl, INTA’s president further offshoot boiler plate counsel being E&J Gallo, gave an entertaining array at George Washington earthly the new law. Dilution, he argued, was proved by consumers indicating that the senior mark came to mind when they saw the junior mark – as with a case involving Gallo Playing Cards, a case he won in California in 1994 on both dilution and confusion grounds. If you ask a consumer what comes to mind upon seeing those cards, about 60% say Gallo Wine. (Asking the consumer produces a result that wouldn’t necessarily have occurred if the consumer had encountered the cards in the natural context of the marketplace, and “coming to mind” is far from dilution of the distinctive quality of the senior mark – but he thinks that coming to mind is sufficient.) Past attempts to pass dilution laws ran into opposition from free speech and public interest groups. Even some trademark owners weren’t certain about dilution. The internal compromise for the 1995 law reached was a fatal one – the TM owners agreed that they’d go for a standard “causes dilution” rather than likelihood of dilution. Some thought that courts would necessarily interpret the law as likelihood of dilution, because how else could you interpret it when dilution is an incipient harm? (Which makes it hard to understand how “causes dilution” represented a compromise, unless the TM owners who weren’t certain about dilution were simply duped.) Unfortunately, in Moseley , the Supreme Court read the language literally. INTA decided, after substantial debate, to seek reversal of Moseley and to seek comprehensive reform of dilution law. Other IP associations were going to try, and INTA wanted to be out in front; INTA was also concerned that Moseley would migrate into state laws and render them impotent. Also, lower court decisions had caused other problems with the FTDA. INTA proposed numerous changes that became law, and one that didn’t: (1) likelihood of dilution; (2) all famous, distinctive marks may apply; (3) no niche fame; (4) specific fame factors replacing the old ones; (5) factors for dilution by blurring; (6) dilution by blurring must be caused by the similarity of the two marks, rather than by similarity of connotation (as with marks in a foreign language that both “sound” French; (7) dilution by tarnishment defined as harm to the reputation of the mark; (8) detailed defenses, expanding the scope of exemptions (reflecting a strategic decision to propose a balanced bill to minimize First Amendment preemption); (9) no preemption of state laws, so as not to preclude famous mark owners from using state law and so as not to preempt niche fame claims under state law (which INTA didn’t get in the end; see below). Again, the opposition came from free speech and public interest groups. Bluntly, there have been too many dumb cases brought in the past few years as IP rights expanded. Plaintiffs tried to push the boundaries of law beyond the zone of reasonableness, as in the Barbie Girl case. Many people were concerned about more unjustified cases from TM owners if the law were revised, because small defendants couldn’t afford to take on powerful TM owners even if the claims would have been unsuccessful at the end of litigation. Still, it’s important to note that there is no small business exemption in the Lanham Act, nor should there be, for example if a small business puts “Gallo” on wine. Every powerful brand started out small. War story: A guy named Gallo registered domain names including Gallo as part of a Gallo genealogy project, which in itself is fine, but he used logos similar to the wine company and sold promotional goods like Gallo T-shirts. Gallo (TM owner) had to sue, and the website was altered. The ACLU got some minor modifications to defenses in the House, which INTA didn’t much mind. And then the bill got stuck in the Senate for a while. Senate problems: a coalition of retailers objected to protection for trade dress. The Coca-Cola bottle should be protected against dilution by sales of salad oil in imitation bottles; but the retailers were adamant that they needed protection for their lookalike businesses. INTA compromised. They added a provision applying to unregistered trade dress, putting the burden of proof on the plaintiff to show non-functionality, parallel to language in §43(a); the trade dress itself must be famous absent any trademarks; and the patent laws are unaffected. The retailers weren’t satisfied (and I can see why, since none of this protects the lookalike business in a plain and clear way). Ultimately, however, the Senate staff accepted the compromise. Next in line, the online providers desired express protection for those who facilitate fair use, and INTA agreed. The free speech interests took a second bite then. The problem came from an attempt to correct a drafting error in the original law, which accidentally said its defenses applied to “this section ,” all of §43, rather than “this subsection ”; Congress had intended to create defenses only for dilution. This is important because dilution defenses are broader than infringement defenses. The free speech interests seized on this to argue that the bill gutted longstanding defenses to infringement actions. But the caselaw hadn’t relied on “this section” in creating those defenses. “Subsection” stayed in the bill. Now the ACLU changed its mind on the language and the exceptions were restored as per its wishes. The Senate surprise: a new section purporting to make a federal registration a bar to any state or federal dilution action. The language doesn’t track the rest of the bill and it’s strangely worded. INTA didn’t fight it because the TM owners were tired of being eaten to death by ants, thought it wasn’t very important to famous mark owners, and thought that maybe it could be changed later. (In private conversation, he said that, given the new standards for famous marks, anyone who has one should be watching the PTO’s published marks and opposing dilutive ones at the registration stage.) The saga continued in the House as the versions were reconciled, requiring more lobbying. But finally it passed, just like the Bill in Schoolhouse Rock. The $64,000 question (can anyone try a case for that amount?) is what practitioners should do with the new law. (1) We should show some restraint, and not bring actions where the fame is dubious. Don’t overreach as with the first law. (2) Respect the defenses, which are in there for a reason. (3) Remember the special rules for unregistered trade dress. Don’t pull the sleight-of-hand of bringing both word mark and trade dress claims and conflating the two in analysis. (4) Educate the judge if you have a solid dilution claim. Don’t make it an afterthought. Explain the harm. Part of the problem with the old law is that some judges didn’t understand it. (5) You now need to prove blurring. It won’t be presumed. The FTDA contains specific factors that you must address. Proof of actual association, such as survey evidence, will be important. Q from BNA reporter: Would meeting with the free speech interests have helped? A: No. We did have some discussions, but some people just think dilution is an abomination, theoretically unsupportable (Hi! [waves hand]). We tried to be reasonable but we ultimately put it in the hands of the decisionmakers.

Tags: dilution, law, inta, mark, defenses

Insurer's claim of no duty to defend fails to gel

Posted on August 19, 2008 in Generic prescription drug list

Ohio Fatality Defense Crowd v. Command Nine, LLC, 2006 WL 3327652 (D. Utah) Years ago, I clerked for then-Chief Judge Edward Becker on the Third Circuit, a great man who is much missed. We had a case about insurance coverage for trademark infringement; one important question was whether trademark infringement counted as “advertising injury.” At the time, almost all precedent suggested that it didn’t, but Judge Becker concluded that, as a trademark is a type of promotional matter, trademark infringement allegations might trigger an insurer’s duty to defend. See Frog, Switch & Mfg. Co., Inc. v. Travelers Ins. Co., 193 F.3d 742, 749 (3d Cir.1999) ("A trademark can be seen as an 'advertising idea': It is a way of marking goods so that they will be identified with a particular source.... [A]llegations of trademark infringement arguably allege misappropriation of an advertising idea."). Since then, more courts have adopted the rationale in Frog, Switch , in the absence of an exclusion for trademark infringement, and this case follows that pattern (indeed, it concludes that the majority rule is that set forth in Frog, Switch ). The policy here covered “advertising injury,” which included “[t]he use of another's advertising idea in your ‘advertisement,’” which in turn was defined as “a notice that is broadcast or published to the general public or specific market segments about your goods, products or services for the purpose of attracting customers or supporters.” There was a standard exclusion for knowingly tortious acts, which isn’t that important at the duty to defend stage because even though the underlying complaint may allege intentional infringement, the plaintiff could ultimately recover without showing intent. The insurer thus can’t use the intentional acts exclusion to defeat the duty to defend against trademark infringement claims. The underlying lawsuit involved alleged breach of a license agreement allowing the defendants to make and sell a patented elastomer gel known as “Gelastic,” “GellyComb,” and “Intelli-Gel.” The relevant claims were for federal and common-law trademark infringement, deceptive trade practices under state law, and misrepresentation and false designation of origin under federal law, all based on defendants’ use of plaintiff’s trade names in advertising, including on their websites and with their goods. The court found that the allegations triggered the insurer’s duty to defend. An “advertising idea” is an idea for calling public attention to a product or business, including discrete images or text in an ad. The trade names GellyComb etc. “expressly describe and promote the gel-like and elastic qualities of the material, calling the public's attention to the desirable qualities of [the] products.” Thus, those trade names are advertising ideas as an average reasonable insurance customer would understand them. (The court probably doesn’t mean to suggest that only descriptive trademarks are advertising ideas; a valid suggestive, arbitrary or fanciful trademark would also convey information and attract attention.) The presence of the trade names on defendants’ websites constitutes advertising, since a business website, “except for the web pages concerning the business's contact information and history, is generally an advertisement for the business's goods, services or products” and counts as a notice broadcast or published to the public. There must also be a causal connection between the advertising and the alleged injury in order for a claim to count as “advertising injury.” The plaintiff sought relief prohibiting defendants from using the trade names on their websites, in advertising or in any other way. This shows a causal connection between the injury and the use of plaintiff’s advertising ideas in defendants’ ads. Defendants’ advertising caused plaintiff’s injury – it didn’t just expose that injury (as, for example, advertising the availability of products that infringed a patent might).

Tags: advertising, trademark, injury, infringement, defendants

2006 Federal Circuit Patent Decisions, Part 1

Posted on August 11, 2008 in Generic medical release

I will periodically post case citations from the Federal Circuit along with the date of the opinion/order and a brief list of the legal topics discussed therein (specifically those with additional embedded case law citations). This posting covers the first eight cases that were appealed from the district court level and decided by the Federal Circuit in 2006. Golden Eagle USA, LLC v. Consolidated Industrial Corp., et al. (01/04/2006): standing to assert patent infringement claims, standing via license agreement Fieldturf International, Inc., et al. v. Sprinturf, Inc., et al. (01/05/2006):

Tags: federal, case, circuit, citations, patent

WIPIP, Panel 4

Posted on July 02, 2008 in Generic prescription drug list

Deborah Gerhart, University of North Carolina School of Law Consumer Investment surrounded by Trademarks: Why it Deserves Plus amid Manifestation Advantage Returns Abstract | Paper She’s beginning a project on the following idea: The corporate owner of the mark is not the sole master of its meaning; it’s important that consumers get some control reflecting their investment in TM meaning. The discourse surrounding consumers in TM cases is patronizing; based on a model of consumers as superabsorbent couch potatoes. One issue: use of terms in dictionaries; dictionaries respond to TM lawyers’ threats even though there’s no cause of action – consumer interests might affect this hypervigilance by TM owners. There is a duty to police, but we should carve out exceptions honoring this consumer investment. (There’s a similar proposal by Deven Desai & Sandra Rierson, relating specifically to genericity.) We could, for example, recognize a type of cultural dilution as nonactionable, for example the appropriation of “spam” for email. It’s not blurring because it doesn’t interfere with source identification, just creates a second parallel narrative. Another possibility: Consumers deserve to be able to use marks to search for information about those marks – informational fair use. Eric Goldman: Likes the idea of investment, and suggests exploring more how consumers use marks to manage their lives – reducing search costs in ways that we don’t usually think about. Also asks about what happens when TM owners change their products – are they harming consumers who have invested in the brand, e.g., New Coke? And wonders about the problem of heterogeneity of meaning. Brands mean different things to different people; whose meanings should we honor? A: This last is why the problem of consumer investment is so important. We can’t just look at the TM owner. Goldman: So how would that play out in an infringement case? How do we account for the brand stories of people who aren’t present in the courtroom? A: We should look at evidence of use, e.g. on the internet. We look for viral meaning, not meaning created by competitors. Lisa Ramsey: “Spam” is a sort of dilution by blurring. Also, consider descriptive terms – consumers have a right to know about the descriptive qualities of products or services regardless of secondary meaning. The descriptive fair use defense may be too limited for consumer needs. A: Spam may have been blurred, but it’s not something that should be actionable nor does she think it was intended to. 9/11 means something different to us now, but the Porsche 911 still has a meaningful narrative. It doesn’t harm in the same way as use by a competitor. My comment: Gerhart made several references to the special harm done by “competitors.” This seems to be calling back to an older idea of TM infringement. Once it was abandoned and noncompetitor use became actionable, TM just kept expanding, causing us to look around for limiting principles. Those principles having failed, we return to competition; likewise, people like Mark McKenna are starting to suggest a materiality requirement for infringement. The interesting thing to me is that competition and materiality are parts of the false advertising test under the Lanham Act; and furthermore, they’ve been implied by courts. So there is a model for doing something like this already in the caselaw. Q: Consumers can contribute to the value of a product – network effects with a computer program, for example – but may not be contributing to the value of the mark – Lotus 123. There are all sorts of investments. A: Agrees. But surprisingly, many uses of marks are expressive – people mostly buy hybrid cars to express something about themselves, despite the price of gas. Tom Bell: Your examples involve consumers having settled on a meaning. But when people are contending to develop meaning, we could get chaos. Peter Jaszi: (Responding to Gerhart’s earlier invocation of “Napsterphobia,” where TM owners irrationally fear loss of control/rights.) What evidence can we use to define and address the problem? A: She’s seen it in her own licensing work – people want to lock up their content so tight it’s useless. William McGeveran, University of Minnesota Law School Rethinking Trademark Fair Use Abstract | Paper Contours of the project: Anytime someone uses a mark to facilitate saying something, we need to at least inquire about whether that’s legitimate and not within the scope of infringement/dilution, though some will perhaps ultimately be correctly suppressed. That puts descriptive and nominative fair use together. There are few really bad decisions when they get all the way to final judgment, but there’s a persistent chill on these types of uses despite the paucity of bad law. McGeveran argues that part of the problem is a failure to conceptualize the relevant defenses – the circuits disagree, the treatises disagree, and even copyright fair use looks better. Moreover, almost all the versions end up collapsing into likelihood of confusion inquiries – for example, this is true with “trademark use” requirements, as well as with nominative fair use. It ends up being more difficult to show nominative fair use than to show lack of confusion. And, as the previous sentence suggests, the burdens of proof get misplaced – if nominative fair use is a substitute for the confusion test, the defendant has to show it’s done nothing else to cause confusion. Relatedly, because these tests are fact-intensive and conflated with confusion, they’re not prone to resolution early on in a case, even summary judgment. So we need to restructure the law to allow early deployment and resolution, detached from fact-intensive considerations. Hard cases will still need further factual development, but that could decrease the chill. Sharon Sandeen: What about a Markman hearing type procedure? In her experience, it did help settle cases. A: That’s the kind of thing he’s thinking. There’s no need to change the FRCP, just doctrine and possibly judicial management practices. The substantive problem with our current defenses is that they depend so much on the facts. My Q: How do you cash this out? A: Use news reporting, use in political campaigns, etc. as explicit carveouts, as with dilution law. It may leave us with keywords as an issue that has to be thought out, but at least we can get rid of suits against artists and Ralph Nader. Farley: You have to answer a question that puzzled the Court in KP Permanent : What does “fair” mean? How can it be fair if there’s confusion? (I think the answer can be Scalia’s in Wal-mart : given the costs of sorting out the few confusing uses from the many nonconfusing ones in a defined subset of cases, the game isn’t worth the candle. This of course makes you rely on generalizations like “most uses in headlines aren’t confusing,” but if it’s good enough for Scalia, why isn’t it good enough for us?) A: This is a problem that shows up in the 9 th Circuit’s rule on remand in KP Permanent , where the court denies summary judgment – the remand makes the problem even worse by complicating the test for descriptive fair use. We must consider how our beautiful tests work structurally and procedurally, or they’ll suppress good uses. Ramsey: consider anti-SLAPP procedures as a model. And consider saying “we just don’t care about certain types of sponsorship confusion,” maybe on constitutional grounds. A: That could be good! Mike Carroll: rather than needing a coherent theory of fair use, we need a more robust theory of TM’s limiting principles outside of confusion. Then we can figure out how to clean up our standards and implement our normative limiting values. Lists of specific safe harbors have pernicious unintended consequences, as we’ve learned in copyright – floors become ceilings; courts draw negative inferences. At a minimum, safe harbors should be defined functionally. And we should also loosen the standards for declaratory judgment so people can get answers quickly. Mark McKenna , Saint Louis University School of Law Trademark Use and the Problem of Source in Trademark Law Abstract | Paper The search cost theory of TM law is not sufficiently rich to give us those limiting principles Carroll talked about. Our failure to find limiting principles once the competition requirement was abandoned has led to the development of the new contender, trademark use – defined roughly to mean a use that indicates source. (You could require affixation as in the statute, but that wreaks havoc on a lot of doctrine.) He’s emotionally on the side of Lemley & Dogan, but ultimately trademark use reduces to confusion – do consumers understand something as an indication of source? – so it doesn’t get us out of the problem. So far the only things that make irrelevant the basic question of source identification are from outside TM: Dastar and Traffix considerations of interference with copyright and patent regimes. This is a much bigger problem than TM use: everything in modern TM law is tied to a concept of consumer understanding of “source,” and the judicial interpretations and practical meanings of source have kept expanding. Even the start time of a baseball game – 7:11 – can indicate sponsorship, so consumers can rationally conclude that anything can. The only logical endpoint is complete control over a mark. But that’s so obviously bad that we need principles to deal with it. And this is search cost theory’s biggest weakness: once we decide consumer confusion is the harm we care about, as opposed to an indicator of some other harm, it’s hard to identify what the stopping point is and it’s very easy to characterize plaintiff’s claims in consumer protection terms. So let’s detach some defenses from confusion, increase the quantum of confusion necessary to support a claim, add a materiality requirement, and maybe other things. Farley: We really need to bring “source” back within some reasonable bounds. McKenna says TMs are functioning in the world more broadly than they used to, so of course the law needs to follow, but she’s not convinced. A: He thinks we can’t go all the way back to trade diversion, but he wouldn’t say we have to follow “source” as far as the market does in practice. We could define source differently for infringement purposes. It might actually matter to some consumer decisions if there is an affiliation between the plaintiff and defendant, and we should be willing to recognize it but perhaps presume irrelevance in certain circumstances. If people start to believe start times signify source, though, then maybe a team shouldn’t be allowed to pick a 7:11 start time to advertise itself. My Q: Nominative fair use, trademark use, and inherent distinctiveness can be seen as a bunch of presumptions, some rebuttable and some not. If we raise the evidentiary standards and don’t allow owner-favorable presumptions (such as occurred in Boston Hockey ), and we regulate surveys carefully, we might find there’s very little evidence of interference with trademark rights in many of these cases. Consumer perceptions, in other words, might not be as trademark-driven as we think. A: He agrees, but it doesn’t solve the problem of kicking cases out early. Calboli: Maybe you’re going back to technical TMs v. unfair competition. A: If he had confidence in our ability to limit the concept of unfair competition (requiring, say, competition ) he might endorse that. But he’s not sure that TM can be distinguished from unfair competition in that way. We need to define the harm agains which we’re protecting people.

Tags: consumer, tm, fair, confusion, style

WIPIP Panel 3

Posted on July 02, 2008 in Generic prescription drug list

Jasmine Abdel-Khalik , University of Missouri-Kansas City School of Law Is a Rose by Fraction Succeeding Fancy Furthermore a Rose? Disconnecting Dilution’s Xerox Checkup from Traditional Trademark Concepts Abstract | Paper Dilution is about the mark itself, unconnected to any goods; it’s about interfering with the story of the mark, rather than interfering with source identification. So how do you tell how similar a mark has to be before it dilutes? Schecter wanted protected marks to be coined, arbitrary, or fanciful, and they’d be protected against identical uses. The change in modern law, allowing acquired distinctiveness to suffice for dilution protection, is important because the mark owner is now adding its own story to an existing term, which means it fights against preconceived ideas – it’s prediluted. So we need to focus on the number of 3 rd -party marks out there, not just whether the claimant has acquired distinctiveness. That is purportedly captured by the fame requirement – it means your story has to have won out. Substantial similarity is the killer question. In the 9 th Circuit TREK and ORBITREK are apparently similar enough for dilution; query whether that would have been similar enough for Schecter. Another case: DOGIVA and CATIVA ; the court skipped past similarity, especially for the latter. Many other –IVA marks exist; there must be something more that triggers substantial similarity. Moseley said mental association wasn’t enough to demonstrate similarity, but didn’t say what would be enough. What about sight, sound, and meaning, the standard infringement trilogy? But with likelihood of confusion, you always look at the mark in context, which influences judgments of similarity. She would like to talk about uniqueness, which to her resembles copyright more than trademark – it’s about originality. Goldman: Invoking substantial similarity from copyright creates a bunch of problems; it’s so unpredictable. Perhaps there’s some more precise test (as copyright has in special subfields). Q: Arbitrariness alone is super-distinctive, but doesn’t deserve dilution protection without fame. If you push for uniqueness, don’t you lose MCDONALD’S and protect all those unknowns? A: She’d offer thinner protection to MCDONALD’S than to a unique mark. Q: The more famous the mark, the less you can dilute it. A: That ties in to the concept that it’s the death by a thousand cuts, not the first cut, that matters. McKenna: There’s a bunch of cognitive psych literature that says some marks are just unassailable. That leaves open what happens to the others. But it’s hard for TM owners to make a straight-faced claim about this – they have to say “we’re really famous, but not that famous.” I think very badly of TM law, but I think worse of copyright. Substantial similarity is just a crapshoot. But you could at least evaluate similarity on basic principles; copyright similarity is about market substitution, but that doesn’t make sense here, and that’s a function of the fact that we don’t know what the harm of dilution is. Irene Calboli: Why do you think the test should be different from the infringement test? Similarity should be required in both cases. What about the old technical/nontechnical trademarks division? (My thought: with confusion, less similarity can trade off with mark strength and relatedness of goods – CATIVA for candy is a different thing than CATIVA for cellphones. I don’t think we want that for dilution.) Lunney: Schecter was writing about technical trademarks, since they were the only ones that could be “TMs.” Why do you want a similarity screen before going to the blurring test? A: Because we’re going to make mistakes on blurring. Q: So why not just fix the blurring doctrine? A: Similarity as a screen allows better evaluation of risks by potential market entrants than a multifactor test. Sean Pager: What about the filtration procedure from copyright; could it be applied to the trademark in evaluating its position relative to other marks (applying semiotic theory)? My comment: The funny thing to me is that when marketers talk about unique brand stories, they often speak in one-word terms – this brand is about YOUTH, or POWER, or whatever. And those are the farthest thing from unique, even though the brands themselves are distinctive and powerful. So seeing dilution as about preserving brand stories makes dilution even more puzzling to me. Katja Weckstr

Tags:

Get a Grip

Posted on July 02, 2008 in Generic biologicals

Getting a good grip from the start is the key to both pitching a baseball and appropriately-managing Major League Baseball's intellectual property. Consider the following from a recent National Law Journal article: According to [plaintiff CDM Fantasy Sports'] lawyer, Rudy Telscher, MLB Advanced Media is expected to decrease "significantly" the number of companies offering its officially licensed fantasy games, therefore denying fantasy leagues the right to use information like player statistics without a license. But CDM is challenging MLB's authority to license anybody, Telscher said, and is specifically seeking to use player statistics without MLB's permission. He said CDM doesn't dispute that it needs an MLB license for trademarked products such as team logos. But statistics are in the public domain, like telephone numbers, he argued. "All we need is the player statistics and we believe we have the right to use them because they're public information," said Telscher of Clayton, Mo.'s Harness, Dickey & Pierce. "The Supreme Court has held that mere raw data where creativity is not involved is not something that would be protected by copyrights. ... I don't see how anyone could argue that player names and stats are something that are protected by copyright." . . . . Attorney Mike Mellis, in-house counsel for MLB Advanced Media, declined to comment on the suit. Jim Gallagher, senior vice president, corporate communications for MLB Advance Media, said that baseball officials are not claiming exclusive rights to player statistics. But if a company is trying to use those statistics as a means of financial gain, he said, then MLB has a legal right to demand a license for their use. "Player statistics are in the public domain. We've never disputed that," Gallagher said. "But if you're going to use statistics in a game for profit, you need a license from us to do that. We own those statistics when they're used for commercial gain." Gallagher demonstrates that when your attorney declines to comment, you probably should as well. Sorry, Jim, but public domain status means that information can be used by anyone for any purpose; the public domain isn't divided into commercial and non-commercial sections. Black's Law Dictionary (7th Edition) describes "public domain" as: "2. The realm of publications, inventions, and processes that are not protected by copyright or patent. Things in the public domain can be appropriated by anyone without liability for infringement." In essence, MLB is seeking to sell what it does not own, hoping to steal first base. Any tee-baller can tell you they can't do that. Back in school, the older kids often tried to trick the younger ones into believing that they needed tickets to climb the stairs or use the bathrooms. Of course, those things are open to all and no tickets are required; the big kids knew that but sought to trade on the naivete of the littler ones for fun and profit. If the big kids at MLB sincerely believe that they can sell tickets to what's open to all, in this case it's not the little kids who are the naive ones. [Update] Labels: Law, Sports

Tags: mlb, public, statistics, kids, domain

Is Buying low cost Drugs online such as Levitra or Generic Tadalafil smart?

Posted on May 15, 2008 in Buy tadalafil

Is Auctioning low face value Drugs on the web conforming owing to Levitra or Generic Tadalafil smart?Ancient history: Jenny Cialis Freeman, Posted Along: 2007-12-29 Yes! The difference midway a agname name medicine along with a generic unique is between the head, synthesize along between the prize. A generic medicine is universally signaled done with the sign of the active quota matching Tadalafil over a manufacturer uses a genre autonym undifferentiated Levitra. However, a manufacturer cannot hold a patent due to a certain chemical agent coextensive as Tadalafil, this is why manufacturers of generic medications related Generic Tadalafil can legally get ready the so-called \"generic\" medicine. They are the commensurate chemically and whereas the active parcel is cognate approbate centrally located offshore Viagra, they have the precise medical spawn. Thus compromising a generic medicine sui generis pays deficient but get ins the singularly not unlike eventuate in that they would from a specimen same as Levitra. Incomparable generic drugs corresponding Generic Tadala! fil, a large citation of the costs incurred ancient history specimen manufacturers of genre term drugs (Levitra) are through research furthermore system further advertising. The damage of geting FDA final lone within the U.S. is big league. Manufacturers of generic drugs affiliated Generic viagra do not have to put away or recover these costs. Consequently, significant bite backlog can be passed onward to you from sites horizontal pillsamples.proceeds this be acquainted little or no overhead expenses additionally commit planet wide. For we consist of already mentioned that no manufacturer can envisage out a patent due to a chemical apparatus consistent due to Tadalafil. Thus generics can seat the exactly comparable active ingredients over the genre pills uninterrupted Levitra. However, names along with structure (constitution as well color) of medications can be more are always patented as well should be treated now the intellectual worth. Thus using the name plus the parent of the blazon pills accept Levitra, a manufacturer producing generic medications declaration be accused of the copyright infringement.! This is why generic pills redound distinctive, they are of a diffe! rent col or and apperceive a divers habit if compared to a pseudonym flag sphere being medially Levitra. Article Catalogue: http://WWW.articlecube.com Cheap Generic Cialis Cheapest Generic Cialis Buy Generic On the web Generic Viagra Cialis Source: http://www.articlecube.com/Article/Is-Buying-low-cost-Drugs-online-such-as-Levitra-or-Generic-Tadalafil-smart-/211078 Weight Loss Blog Buy OEM Software Cheap AutoCAD 2005 Cheap Adobe Photoshop Cheap Adobe

Tags:

Johnson & Johnson - Topamax: defense, defense!

Posted on May 13, 2008 in Antibiotic

It was a big day for Johnson & Johnson's legal teams yesterday as the drugmaker attempted to block the launch of generic versions of its Topamax epilepsy drug, and started drawing up the defense for its oral solution formulation of blockbuster schizophrenia treatment Risperdal. The most pressing threat to its business came from Mylan Laboratories, which last month won US approval to sell generic versions of three Topamax doses with combined annual sales of approximately $1.4 billion. J&J was trying to win an injunction against the launch of Mylan's generic last night and had asked for an initial hearing to put its case forward.Mylan is thought to be debating whether to launch its generic, which could provide enormous near-term revenues but also ay it open to sizeable damages should it lose an ongoing patent infringement lawsuit filed by J&J. As the first to file for approval of generic Topamax, Mylan has six months' exclusivity in the marketplace so could reap a rich harvest before other generics enter the field.J&J has always insisted that its Topamax patents are valid until 2008, so could lose two years of blockbuster sales should Mylan prevail in the patent infringement suit. Source: PharmaTimes Sphere: Related Content Cheap Microsoft PhotoDraw 2.0 Cheap Borland Office Enterprise 2007 cheap Macromedia Dreamweaver 8

Tags: cheap, topamax, generic, mylan, patent

Discovery Science Channel Segment on Bee Venom Therapy

Posted on April 30, 2008 in Compound pharmacy

Watch the Video Cheap Software oem cheap AutoCAD 2005 Buy OEM Software

Tags:

Initial determination of infringement by Qualcomm of Broadcom patent

Posted on April 18, 2008 in Diabetes erectile dysfunction

On October 10, ITC Administrative Law Judge Charles Bullock found three patents asserted by Broadcom to be valid and claims of one of the patents to be infringed by Qualcom. Braodcom said infringing products of Qualcomm include cellular baseband processor chips that comprise Qualcomm's core suite of multimedia and convergence handset platforms. Qualcomm said that Bullock recommended that no downstream remedies be implemented against the wireless handsets of third parties that incorporate Qualcomm chips and software. cheap Office Enterprise 2007 Cheap Special Offer 6 Cheap Software cheap Macromedia Dreamweaver 8

Tags:

Sponsors

Search